Back to Search Start Over

Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in the Third-Line or Later Treatment Setting for Relapsed or Refractory Large B-cell Lymphoma in the United States

Authors :
Christopher Parker
Fei Fei Liu
Kristen A. Deger
Conrado Franco-Villalobos
Irina Proskorovsky
Scott J. Keating
Sonja Sorensen
Source :
Advances in Therapy. 40:2355-2374
Publication Year :
2023
Publisher :
Springer Science and Business Media LLC, 2023.

Subjects

Subjects :
Pharmacology (medical)
General Medicine

Details

ISSN :
18658652 and 0741238X
Volume :
40
Database :
OpenAIRE
Journal :
Advances in Therapy
Accession number :
edsair.doi...........d9d0d87ae98c21bf12b22d5bac6e9062
Full Text :
https://doi.org/10.1007/s12325-023-02444-x
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details